Effect of immunization on the development of latent ganglionic infection in mice challenged intravaginally with herpes simplex virus types 1 and 2
- PMID: 210669
- DOI: 10.1016/0002-9378(78)90248-x
Effect of immunization on the development of latent ganglionic infection in mice challenged intravaginally with herpes simplex virus types 1 and 2
Abstract
Immunization of BALB/c mice with virulent and avirulent strains of HSV-1 resulted in high levels of neutralizing antibody and protected against both the lethal effect of the virus and the development of a latent ganglionic infection when animals were challenged by the intravaginal route. In animals immunized with avirulent strain of HSV-2 and challenged with a high virulent strain of HSV-2, substantial protection against death was observed despite low levels of neutralizing antibody. Nineteen per cent of the survivors, however, developed a latent ganglionic infection. Relatively little protection was observed in mice immunized with HSV-1 and challenged with HSV-2.
Similar articles
-
Latent infection of sensory ganglia with herpes simplex virus: efficacy of immunization.Science. 1975 May 30;188(4191):938-40. doi: 10.1126/science.166432. Science. 1975. PMID: 166432
-
Immune responses in mice against herpes simplex virus: mechanisms of protection against facial and ganglionic infections.Infect Immun. 1981 Jan;31(1):267-75. doi: 10.1128/iai.31.1.267-275.1981. Infect Immun. 1981. PMID: 6260662 Free PMC article.
-
Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination.J Virol. 1988 May;62(5):1530-4. doi: 10.1128/JVI.62.5.1530-1534.1988. J Virol. 1988. PMID: 2833606 Free PMC article.
-
The quest for a herpes simplex virus vaccine: background and recent developments.Vaccine. 1986 Sep;4(3):138-50. doi: 10.1016/0264-410x(86)90001-0. Vaccine. 1986. PMID: 3020819 Review.
-
Latent herpes simplex virus and the nervous system,Curr Top Microbiol Immunol. 1975;70:31-50. doi: 10.1007/978-3-642-66101-3_2. Curr Top Microbiol Immunol. 1975. PMID: 169103 Review. No abstract available.
Cited by
-
Latent herpes simplex virus infections in sensory ganglia of hairless mice prevented by acycloguanosine.Antimicrob Agents Chemother. 1979 May;15(5):723-9. doi: 10.1128/AAC.15.5.723. Antimicrob Agents Chemother. 1979. PMID: 230784 Free PMC article.
-
Prepubertal vaccination of mice against experimental infection of the genital tract with type 2 herpes simplex virus.Arch Virol. 1980;64(4):329-38. doi: 10.1007/BF01320618. Arch Virol. 1980. PMID: 6249243 Free PMC article.
-
Effective vaccination against long-term gammaherpesvirus latency.J Virol. 2003 Feb;77(4):2522-9. doi: 10.1128/jvi.77.4.2522-2529.2003. J Virol. 2003. PMID: 12551990 Free PMC article.
-
Herpes simplex virus 2 (HSV-2) infected cell proteins are among the most dominant antigens of a live-attenuated HSV-2 vaccine.PLoS One. 2015 Feb 6;10(2):e0116091. doi: 10.1371/journal.pone.0116091. eCollection 2015. PLoS One. 2015. PMID: 25658852 Free PMC article.
-
The quantity of latent viral DNA correlates with the relative rates at which herpes simplex virus types 1 and 2 cause recurrent genital herpes outbreaks.J Virol. 1998 Apr;72(4):2760-4. doi: 10.1128/JVI.72.4.2760-2764.1998. J Virol. 1998. PMID: 9525595 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources